ROIDCheck: Building the World’s First Steroid Drug Checking Program
Overview:
Conducted across 2024–2025, the program provided real-world data on the composition, purity, and safety of anabolic-androgenic steroids (AAS) in Australia. Drawing on collaborations between health services, peer networks, and harm reduction practitioners, ROIDCheck demonstrates how community-led drug checking can generate actionable intelligence, support safer use, and reshape health engagement among people who use performance and image-enhancing drugs.
Watch the presentation
About the presenter
Dr. Timothy Piatkowski is an NHMRC Emerging Leadership Fellow at The University of Queensland. He is a peer researcher, using his lived experience and close community partnerships to enable innovative health programs which are accessible and translatable.He has received over $7.5 million (5.8 as CI) in research funding and has >160 outputs, many of which are impactful, having won the APSAD 2025 EMCR Most Highly Cited Paper for his innovative work on trenbolone (a potent steroid). His work has been recognised through multiple national awards, including the AIVL Peer Researcher Recognition Award (2024) and the APSAD Kyp Kypri Early Career Researcher Award (2024).
Dr. Piatkowski leads pioneering, peer-led initiatives such as the world’s first steroid checking service (ROIDCheck) and the Steroid QNECT program, both of which are nationally award winning programs currently inspiring international initiatives to follow suite (e.g., Switzerland, UK).